CD19-CAR_Lenti_ALLO / Bambino Gesu Hospital - LARVOL DELTA

Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL (clinicaltrials.gov) - P1 | N=24 | Recruiting | Sponsor: Bambino Gesù Hospital and Research Institute | Not yet recruiting ➔ Recruiting | Initiation date: Jan 2024 ➔ Apr 2024

CAR T-Cell Therapy • Enrollment open • Trial initiation date • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • Hematological Malignancies • Leukemia • Oncology • Pediatrics • CD19 • CD22